686 related articles for article (PubMed ID: 14977447)
1. Effect of Maitake (Grifola frondosa) D-Fraction on the activation of NK cells in cancer patients.
Kodama N; Komuta K; Nanba H
J Med Food; 2003; 6(4):371-7. PubMed ID: 14977447
[TBL] [Abstract][Full Text] [Related]
2. Effects of D-Fraction, a polysaccharide from Grifola frondosa on tumor growth involve activation of NK cells.
Kodama N; Komuta K; Sakai N; Nanba H
Biol Pharm Bull; 2002 Dec; 25(12):1647-50. PubMed ID: 12499658
[TBL] [Abstract][Full Text] [Related]
3. Soluble β-glucan from Grifola frondosa induces tumor regression in synergy with TLR9 agonist via dendritic cell-mediated immunity.
Masuda Y; Nawa D; Nakayama Y; Konishi M; Nanba H
J Leukoc Biol; 2015 Dec; 98(6):1015-25. PubMed ID: 26297795
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of cytotoxicity of NK cells by D-Fraction, a polysaccharide from Grifola frondosa.
Kodama N; Asakawa A; Inui A; Masuda Y; Nanba H
Oncol Rep; 2005 Mar; 13(3):497-502. PubMed ID: 15706424
[TBL] [Abstract][Full Text] [Related]
5. Can maitake MD-fraction aid cancer patients?
Kodama N; Komuta K; Nanba H
Altern Med Rev; 2002 Jun; 7(3):236-9. PubMed ID: 12126464
[TBL] [Abstract][Full Text] [Related]
6. Maitake extracts and their therapeutic potential.
Mayell M
Altern Med Rev; 2001 Feb; 6(1):48-60. PubMed ID: 11207456
[TBL] [Abstract][Full Text] [Related]
7. Maitake beta-glucan enhances therapeutic effect and reduces myelosupression and nephrotoxicity of cisplatin in mice.
Masuda Y; Inoue M; Miyata A; Mizuno S; Nanba H
Int Immunopharmacol; 2009 May; 9(5):620-6. PubMed ID: 19249389
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a novel maitake (Grifola frondosa) protein that activates natural killer and dendritic cells and enhances antitumor immunity in mice.
Tsao YW; Kuan YC; Wang JL; Sheu F
J Agric Food Chem; 2013 Oct; 61(41):9828-38. PubMed ID: 24020458
[TBL] [Abstract][Full Text] [Related]
9. Maitake D-Fraction enhances antitumor effects and reduces immunosuppression by mitomycin-C in tumor-bearing mice.
Kodama N; Murata Y; Asakawa A; Inui A; Hayashi M; Sakai N; Nanba H
Nutrition; 2005 May; 21(5):624-9. PubMed ID: 15850970
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of soluble β-glucans extracted from Grifola frondosa induces systemic antitumor immune response and decreases immunosuppression in tumor-bearing mice.
Masuda Y; Inoue H; Ohta H; Miyake A; Konishi M; Nanba H
Int J Cancer; 2013 Jul; 133(1):108-19. PubMed ID: 23280601
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of MD-Fraction on tumor metastasis: involvement of NK cell activation and suppression of intercellular adhesion molecule (ICAM)-1 expression in lung vascular endothelial cells.
Masuda Y; Murata Y; Hayashi M; Nanba H
Biol Pharm Bull; 2008 Jun; 31(6):1104-8. PubMed ID: 18520039
[TBL] [Abstract][Full Text] [Related]
12. Potential antitumor activity of a low-molecular-weight protein fraction from Grifola frondosa through enhancement of cytokine production.
Kodama N; Mizuno S; Nanba H; Saito N
J Med Food; 2010 Feb; 13(1):20-30. PubMed ID: 20136432
[TBL] [Abstract][Full Text] [Related]
13. Administration of a polysaccharide from Grifola frondosa stimulates immune function of normal mice.
Kodama N; Murata Y; Nanba H
J Med Food; 2004; 7(2):141-5. PubMed ID: 15298759
[TBL] [Abstract][Full Text] [Related]
14. Maitake Pro4X has anti-cancer activity and prevents oncogenesis in BALBc mice.
Roldan-Deamicis A; Alonso E; Brie B; Braico DA; Balogh GA
Cancer Med; 2016 Sep; 5(9):2427-41. PubMed ID: 27401257
[TBL] [Abstract][Full Text] [Related]
15. Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation.
Martí F; Pardo N; Peiró M; Bertran E; Amill B; García J; Cubells J; Rueda F
Exp Hematol; 1995 Dec; 23(14):1445-52. PubMed ID: 8542930
[TBL] [Abstract][Full Text] [Related]
16. Antitumoral Effects of D-Fraction from Grifola Frondosa (Maitake) Mushroom in Breast Cancer.
Alonso EN; Ferronato MJ; Gandini NA; Fermento ME; Obiol DJ; López Romero A; Arévalo J; Villegas ME; Facchinetti MM; Curino AC
Nutr Cancer; 2017 Jan; 69(1):29-43. PubMed ID: 27892708
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide-mediated antitumor activity induced by the extract from Grifola frondosa (Maitake mushroom) in a macrophage cell line, RAW264.7.
Sanzen I; Imanishi N; Takamatsu N; Konosu S; Mantani N; Terasawa K; Tazawa K; Odaira Y; Watanabe M; Takeyama M; Ochiai H
J Exp Clin Cancer Res; 2001 Dec; 20(4):591-7. PubMed ID: 11876556
[TBL] [Abstract][Full Text] [Related]
18. Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer.
Conlon KC; Lugli E; Welles HC; Rosenberg SA; Fojo AT; Morris JC; Fleisher TA; Dubois SP; Perera LP; Stewart DM; Goldman CK; Bryant BR; Decker JM; Chen J; Worthy TA; Figg WD; Peer CJ; Sneller MC; Lane HC; Yovandich JL; Creekmore SP; Roederer M; Waldmann TA
J Clin Oncol; 2015 Jan; 33(1):74-82. PubMed ID: 25403209
[TBL] [Abstract][Full Text] [Related]
19. Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.
Miller JS; Tessmer-Tuck J; Pierson BA; Weisdorf D; McGlave P; Blazar BR; Katsanis E; Verfaillie C; Lebkowski J; Radford J; Burns LJ
Biol Blood Marrow Transplant; 1997 Apr; 3(1):34-44. PubMed ID: 9209739
[TBL] [Abstract][Full Text] [Related]
20. Maitake α-glucan promotes differentiation of monocytic myeloid-derived suppressor cells into M1 macrophages.
Masuda Y; Nakayama Y; Shimizu R; Naito K; Miyamoto E; Tanaka A; Konishi M
Life Sci; 2023 Mar; 317():121453. PubMed ID: 36709912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
